IL-13 receptor for tumor specific T-cell immunotherapy α 2 α Target chimeric antigen receptor

摘要

Some of the embodiments and methods of the compositions provided herein include the human IL-13 receptor α The present invention relates to a chimeric antigen receptor (car) specifically binding to the extracellular domain of 2 (il13ra2), a cell containing the car, and a cell-based immunotherapy targeting cancer cells (solid tumor cells, etc.).